I.V Papavrine for Labor Induction in Term PROM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

I.V Papavrine for Labor Induction in Term PROM — Stella

Recruiting

Back to Premature Rupture of Membranes trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Israel

Galilee Medical Center, Nahariya, Israel

Key details

Phase

Post-approval study

Sponsor

Western Galilee Hospital-Nahariya

Enrollment target

~110 participants

Started

October 2025

Primary completion

October 2027

Age range

18 Years – 45 Years

Sex

Female only

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov